ACS Revenue and Competitors
Estimated Revenue & Valuation
- ACS's estimated annual revenue is currently $106.6M per year.
- ACS's estimated revenue per employee is $262,500
Employee Data
- ACS has 406 Employees.
- ACS grew their employee count by 78% last year.
ACS's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Superintendent | Reveal Email/Phone |
ACS Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $150.2M | 563 | 12% | N/A | N/A |
#2 | $7.3M | 46 | 7% | $84.4M | N/A |
#3 | $110.5M | 421 | 18% | N/A | N/A |
#4 | $41.6M | 180 | 7% | N/A | N/A |
#5 | $27.3M | 130 | 23% | N/A | N/A |
#6 | $4M | 27 | -57% | N/A | N/A |
#7 | $2.3M | 0 | N/A | $381.6M | N/A |
#8 | $22.5M | 107 | 19% | N/A | N/A |
#9 | $20.4M | 97 | 5% | $47.9M | N/A |
#10 | $12.7M | 67 | 29% | N/A | N/A |
What Is ACS?
Narional Erosion control and Right-of-Way reclamation specialists. Including environmental consulting and mitigation. We pride ourselves on the quailty of our work and our reputation to provide immediate response, competitive pricing and the latest technologies to enhance our final product.
keywords:N/A
N/A
Total Funding
406
Number of Employees
$106.6M
Revenue (est)
78%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ACS News
Neha Kamat Receives ACS Synthetic Biology Young Investigator Award. Kamat was recognized for her early-career contributions to the field.
Neha Kamat Receives ACS Synthetic Biology Young Investigator Award. Kamat was recognized for her early-career contributions to the field.
Patients with acute coronary syndromes complicated by cardiogenic shock (ACS-CS) who undergo PCI fare similarly regardless of whether their...
Patients with acute coronary syndromes complicated by cardiogenic shock (ACS-CS) who undergo PCI fare similarly regardless of whether their...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $126.3M | 406 | 49% | $109.4M |
#2 | $106.6M | 406 | -13% | N/A |
#3 | $35M | 406 | 5% | N/A |
#4 | $106.6M | 406 | N/A | N/A |
#5 | N/A | 406 | N/A | N/A |